The table below shows Contineum Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$11.65M
$10.99M
$14.06M
$13.71M
$9.73M
$7.90M
SG&A
CTNM annual revenue (10-K history)
Contineum Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2024. That is down 100.0% from $50.00M in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.